Educational Video Series

R. Maarten Egeler, MD, PhD

Maarten Egeler

Professor Maarten Egeler is an internationally recognized expert in the treatment and research of stem cell transplantation, histiocytoses, and bone tumours. After graduation in 1985 from the University of Leiden, and his residency in paediatrics in Amsterdam, the Netherlands, he was awarded a research fellowship from the Royal Dutch Academy of Arts and Sciences at the University of Minnesota, where he worked on his PhD thesis titled: Langerhans cell histiocytoses and other histiocytic disorders, successfully defended in 1993.

Subsequently he joined the Division of Pediatric Hematology and Oncology at the Erasmus University of Rotterdam, and after five years he was appointed Associate Professor of Oncology and Pediatrics at the Southern Alberta Children's Cancer Program of the University of Calgary, Canada. In 2000, he became the Director of the Division of Pediatric Immunology, Hematology, Oncology, Bone Marrow Transplantation and Auto-immune disease at the Leiden University Medical Center. In 2011, he moved back to Canada and accepted the position of Section Head, Stem Cell Transplantation within the Division of Hematology and Oncology at The Hospital for Sick Children (SickKids) in Toronto. He is a holder of the Garron Family Chair in Childhood Cancer Research and a professor at the University of Toronto.

Dr. Egeler has served for a decade as Board Member of the Pediatric Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT). He has been President of the International Society of Pediatric Oncology (SIOP), the President of the international Histiocyte Society (Board-member for 12 years), and President of the Dutch Childhood Oncology Group (DCOG) (active Board-member for 10 years). Currently he is active within the Oncology Disorders Strategy Group and the Cellular Therapeutic Strategy Group of the Pediatric Blood and Marrow Transplant Consortium (PBMTC).

His research has been dedicated to Stem Cell Transplantation with a main focus on Graft-versus-Host Disease opposed to Graft-versus Leukemia and mesenchymal stem cells. He considers Stem Cell Transplantation the platform for cell therapy and innovation. Furthermore, he has great interest and expertise in the immunologic aspects of dendritic cells in relation to Langerhans cell histiocytoses.

Dr. Egeler has authored and co-authored more than 225 manuscripts and chapters in national and international journals, with highlights in Blood, Journal of Experimental Medicine, Nature Reviews and Nature Medicine. He is still mentoring ten PhD students at the University of Leiden, but will develop something similar at SickKids.



View Dr. Egeler's video: Overview of LCH in Children
Return to Educational Video Series page

Share with Others

© Histiocytosis Association, Inc.
332 North Broadway, Pitman, New Jersey  08071 USA
Phone: +1 856-589-6606 | Fax: +1 856-589-6614
US & Canada Toll-Free: 1-800-548-2758 
Privacy | DisclaimerState Fundraising Notices 
Tax ID: 22-2827069 | Contact Us 
Follow Me on Pinterest   

¿No Habla Inglés? Si usted puede escribirme sus preguntas y preocupaciones a la dirección de correo electrónico: Nosotros podremos responderle tan pronto nos sea possible. Gracias!